SCHEMBL7812918

SCHEMBL7812918

COc1c(F)ccc(C(=O)c2c(Cc3ccccc3)sc3ccccc23)c1F

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 9/20 0.45
▸ CNR1 P21554 6/20 0.43
▸ ALDH1A1 P00352 2/20 0.41
▸ MAPT P10636 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ PTPN1 P18031 9/20 0.41
▸ USP2 O75604 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ RECQL P46063 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6337585 0.76 CNR2 (0.75) CNR2CNR1ALDH1A1MAPTMEN1
SCHEMBL7816077 0.75 CNR2 (0.51) CNR2CNR1ALDH1A1MAPTMEN1
SCHEMBL7816703 0.73 CNR2 (0.57) CNR2CNR1ALDH1A1PTPN1
SCHEMBL7816066 0.73 CNR2 (0.54) CNR2CNR1ALDH1A1LMNAPTPN1
SCHEMBL6235979 0.73 MAPT (0.50) ALDH1A1MAPTMEN1LMNAPOLB
SCHEMBL11731930 0.72 PTPN1 (0.46) CNR2ALDH1A1MAPTMEN1LMNA
SCHEMBL6344128 0.70 PTPN1 (0.53) CNR2CNR1MAPTMEN1LMNA
SCHEMBL28053024 0.68 ALDH1A1 (0.51) ALDH1A1MAPTMEN1LMNAPOLB
SCHEMBL7817127 0.68 CNR2 (0.61) CNR2CNR1ALDH1A1MAPTMEN1
SCHEMBL13799834 0.67 PTPN1 (0.57) CNR2PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1077970-A1 11-ARYL-BENZO(B)NAPHTHO(2,3-D)FURANS AND 11-ARYL-BENZO(B)NAPHTHO(2,3-D)THIOPHENES USEFUL IN THE TREATMENT OF INSULIN RESISTANCE AND HYPERGLYCEMIA AMERICAN HOME PRODUCTS CORPORATION (US) 2001-02-28 — — EP disclosed
US-6110962-A FOR TREATING INSULIN RESISTANCE, TYPE II DIABETES, HYPERGLYCEMIA, MODULATING INSULIN LEVELS IN MAMMALS AMERICAN HOME PRODUCTS CORPORATION (US) 2000-08-29 — — US disclosed
WO-1999058521-A1 11-ARYL-BENZO[B]NAPHTHO[2,3-D]FURANS AND 11-ARYL-BENZO[B]NAPHTHO[2,3-D]THIOPHENES USEFUL IN THE TREATMENT OF INSULIN RESISTANCE AND HYPERGLYCEMIA AMERICAN HOME PRODUCTS CORPORATION (US) 1999-11-18 — — WO disclosed
Send feedback